Other

Is there a generic drug for Symbicort?

Is there a generic drug for Symbicort?

A generic version of Symbicort is available. The generic version, which contains budesonide and formoterol, is equivalent to Symbicort. The generic version may also be a cheaper alternative to the brand name inhaler.

Is Symbicort considered a corticosteroid?

Symbicort (generic name: budesonide and formoterol) contains an inhaled corticosteroid (“steroid”) known as budesonide to reduce inflammation in the lungs, but also contains a medicine known as formoterol. Formoterol is a long-acting inhaled bronchodilator that relaxes muscles in the airways to improve breathing.

Is Symbicort a maintenance drug?

COPD treatment usually includes a combination of maintenance medications and rescue medications. Symbicort, which includes a corticosteroid and a long-acting beta2-agonist, is considered a maintenance medication.

When did Symbicort become generic?

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be July 29, 2023….Summary for SYMBICORT.

International Patents: 257
Drug Sales Revenues: Drug sales revenues for SYMBICORT

How much does Symbicort cost at Walmart?

The average cost of Symbicort is $589.78 for 10.200, 10.2GM of 160-4.5MCG/ACT Aerosol….Average 12 Month Prices for Symbicort.

Pharmacy Symbicort Retail Price Symbicort SingleCare Price
Walmart $483.40 $324.77
Walgreens $451.23 $307.21

Is Symbicort a strong inhaler?

A specific strength of Symbicort (160/4.5) may be used as a maintenance treatment in people with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema, to reduce inflammation and airflow obstruction.

Why does Symbicort cost so much?

These patents granted manufacturers market exclusivity on their product, and prevented affordable generic alternatives from being manufactured. These patents also created a lack of competition in the inhaler space which allowed for large price increases.

Who manufactures the generic Symbicort?

The FDA has granted tentative approval of the first generic version of AstraZeneca’s blockbuster drug Symbicort. Viatris and Kindeva Drug Delivery secured the tentative approval but still face a patent barrier to launch, with AstraZeneca prevailing in a court case last week.